These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 5814753)

  • 1. [Interpretation of end plate potentials (EPP) and miniature end plate potentials (MEPP) by means of the Linc-8-computer, demonstrated with in vitro recordings from intercostal muscle of a patient with myasthenia gravis].
    Kruckenberg P; Bauer H
    Pflugers Arch; 1969; 307(2):R106. PubMed ID: 5814753
    [No Abstract]   [Full Text] [Related]  

  • 2. A new test for myasthenia gravis: recording of miniature end-plate potentials in situ.
    Lovelace RE; Stone R; Zablow L
    Neurology; 1970 Apr; 20(4):385. PubMed ID: 5535003
    [No Abstract]   [Full Text] [Related]  

  • 3. Facilitatory effects of 4-aminopyridine on neuromuscular transmission in disease states.
    Kim YI; Goldner MM; Sanders DB
    Muscle Nerve; 1980; 3(2):112-9. PubMed ID: 6245355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [On the impaired neuromuscular transmission in myasthenia gravis].
    Kruckenberg P; Pontzen W; Sandweg R; Bauer H
    Z Neurol; 1971; 200(2):158-73. PubMed ID: 4108119
    [No Abstract]   [Full Text] [Related]  

  • 5. Congenital myasthenia: end-plate acetylcholine receptors and electrophysiology in five cases.
    Vincent A; Cull-Candy SG; Newsom-Davis J; Trautmann A; Molenaar PC; Polak RL
    Muscle Nerve; 1981; 4(4):306-18. PubMed ID: 7254233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spontaneous end-plate activity in normal subjects and in patients with myasthenia gravis.
    Grob D
    Ann N Y Acad Sci; 1971 Sep; 183():248-69. PubMed ID: 5287826
    [No Abstract]   [Full Text] [Related]  

  • 7. Some different aspects of post-tetanic phenomena in myasthenia gravis.
    Pinelli P; Arrigo A; Mille T
    Electroencephalogr Clin Neurophysiol; 1967 Aug; 23(2):190. PubMed ID: 4166736
    [No Abstract]   [Full Text] [Related]  

  • 8. Acetylcholine receptors and end-plate electrophysiology in myasthenia gravis.
    Ito Y; Miledi R; Vincent A; Newsom-Davis J
    Brain; 1978 Jun; 101(2):345-68. PubMed ID: 667602
    [No Abstract]   [Full Text] [Related]  

  • 9. End-plate potentials in experimental autoimmune myasthenia gravis in rats.
    Lambert EH; Lindstrom JM; Lennon VA
    Ann N Y Acad Sci; 1976; 274():300-18. PubMed ID: 1066990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of miniature end-plate potential amplitude in extraocular and limb muscles in an animal model of myasthenia gravis.
    Zahm DS; Kim YI; Liu HH; Johns TR
    Exp Neurol; 1983 Apr; 80(1):258-62. PubMed ID: 6832272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The pathophysiology of some disorders of neuromuscular transmission].
    Elmqvist D
    Tidsskr Nor Laegeforen; 1971 Apr; 91(11):816-9. PubMed ID: 5089803
    [No Abstract]   [Full Text] [Related]  

  • 12. [Motor endplate and the muscle fibre].
    Trontelj M
    Neuropsihijatrija; 1973; 21(3-4):187-91. PubMed ID: 4805056
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison between huperzine A, tacrine, and E2020 on cholinergic transmission at mouse neuromuscular junction in vitro.
    Lin JH; Hu GY; Tang XC
    Zhongguo Yao Li Xue Bao; 1997 Jan; 18(1):6-10. PubMed ID: 10072886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuromusclar junction and myasthenic crisis.
    Mayer RF; Albuquerque EX; Rash JE; Hudson CS
    Trans Am Neurol Assoc; 1977; 102():100-4. PubMed ID: 616082
    [No Abstract]   [Full Text] [Related]  

  • 15. End-plate voltage-gated sodium channels are lost in clinical and experimental myasthenia gravis.
    Ruff RL; Lennon VA
    Ann Neurol; 1998 Mar; 43(3):370-9. PubMed ID: 9506554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myasthenia in frogs immunized against cholinergic-receptor protein.
    Nastuk WL; Niemi WD; Alexander JT; Chang HW; Nastuk MA
    Am J Physiol; 1979 Jan; 236(1):C53-7. PubMed ID: 219703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Freeze-fracture, labelled-replica, and electrophysiological studies of junctional fold destruction in myasthenia gravis and experimental autoimmune myasthenia gravis.
    Rash JE; Hudson CS; Albuquerque EX; Eldefrawi ME; Mayer RF; Graham WF; Johnson TJ; Giddings FD
    Ann N Y Acad Sci; 1981; 377():38-60. PubMed ID: 6951483
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pathophysiology of myasthenia gravis and the myasthenic syndrome].
    Struppler A; Ruprecht EO
    Anaesthesist; 1971 Jan; 20(1):29-35. PubMed ID: 4322997
    [No Abstract]   [Full Text] [Related]  

  • 19. Short-term effects of prednisolone on neuromuscular transmission in normal rats and those with experimental autoimmune myasthenia gravis.
    Kim YI; Goldner MM; Sanders DB
    J Neurol Sci; 1979 Apr; 41(2):223-34. PubMed ID: 220391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The kinetics of transmitter release in myasthenia gravis. I. An electrophysiological analysis of the storage of transmitter.
    Bergmans J; Rosselle N; Verheyen G; Schellens L
    Electromyogr Clin Neurophysiol; 1972; 12(5):443-88. PubMed ID: 4350884
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.